Acute kidney injury: cell cycle arrest biomarkers win race for AKI diagnosis.
Nat Rev Nephrol
; 10(12): 683-5, 2014 12.
Article
in En
| MEDLINE
| ID: mdl-25347946
FDA approval of the first device to use novel biomarkers of kidney damage to assess risk of acute kidney injury (AKI) potentially brings forward diagnosis of moderate-to-severe AKI to a time frame that could enable early intervention. Although the device awaits greater scrutiny, its approval marks the beginning of a new era.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Insulin-Like Growth Factor Binding Proteins
/
Matrix Metalloproteinase 2
/
Early Diagnosis
/
Acute Kidney Injury
/
Cell Cycle Checkpoints
Type of study:
Diagnostic_studies
/
Screening_studies
Aspects:
Determinantes_sociais_saude
Limits:
Female
/
Humans
/
Male
Country/Region as subject:
America do norte
Language:
En
Journal:
Nat Rev Nephrol
Journal subject:
NEFROLOGIA
Year:
2014
Document type:
Article
Affiliation country:
Australia
Country of publication:
United kingdom